UK Regulatory Body Rejects Novartis Kidney Cancer Drug
This is a discussion on UK Regulatory Body Rejects Novartis Kidney Cancer Drug within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; Novartis AG's cancer drug Afinitor (everolimus) has been rejected for patients with kidney cancer by Britain's health costs ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-06-2010, 11:10 PM
|
|||
|
|||
UK Regulatory Body Rejects Novartis Kidney Cancer Drug
Novartis AG's cancer drug Afinitor (everolimus) has been rejected for patients with kidney cancer by Britain's health costs watchdog, which says it is too pricey for the country's taxpayer-funded National Health Service (NHS).
Reuters Health Information More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA rejects new indication for Spectrum drug | industry_news | Biotechnology News | 0 | 10-09-2009 10:54 AM |
| EU Approves Novartis' Bone Drug for Use in Men | industry_news | Other Clinical Pharmacy News | 0 | 10-01-2008 02:45 PM |
| UK Cancer Experts Deplore NICE Decision on Kidney Cancer Drugs | industry_news | Other Clinical Pharmacy News | 0 | 08-26-2008 09:00 PM |
| Breast Cancer Survival Drops With Increasing Body Mass Index | industry_news | Other Clinical Pharmacy News | 0 | 07-28-2008 02:56 PM |
| Androgen Blockade for Prostate Cancer Leads to Changes in Body Composition | industry_news | Other Clinical Pharmacy News | 0 | 07-09-2008 05:59 PM |
© 2008 DrugManagementForum™ powered by |
 |